NSTG NanoString Technologies Inc

Fifth annual event will explore the latest advancements in spatial biology highlighting new products and customer success stories

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit, September 19th. The two-hour virtual event will showcase advances in the rapidly expanding field of spatial biology with talks from scientific leaders harnessing the power and utility of our spatial platforms for discovery, drug development, the quest for biomarkers and comprehensive data interrogation from clinical trials.

“The Spatial Genomics Summit is an educational forum for showcasing hot-off-the-press datasets and breakthrough applications,” said Joe Beechem, Chief Scientific Officer of NanoString. “In addition, the summit is an efficient way for researchers to see what their peers are achieving using our GeoMx Digital Spatial Profiler (DSP) and CosMx Spatial Molecular Imager (SMI) platforms.”

Summit highlights include:

• Vikram Devgan, Ph.D. Senior Director, Product Management, NanoString: Introduction of new spatial biology products, including the 570-plex GeoMx® IO Proteome Atlas (IPA) and CosMx™ 6K Discovery Panel RNA assay.

• Joseph Beechem, Ph.D. Chief Scientific Officer, NanoString: Spatial Biology Roadmap: Transforming the Information Content Obtained from a Single Tissue Section. Single cell spatial imager performance comparison, CosMx 6K RNA dataset release, and neuroscience applications.

• Nic West, Ph.D. Senior Lecturer, Griffith University: Mapping the Spatial Cellular and Subcellular Heterogeneity of type 2 Inflammation. Application of GeoMx DSP and CosMx SMI to obtain greater insight into the way cells are operating to drive dysfunctional immune activity.

• Sophie Wehrkamp-Richter, Ph.D. Sr. Product Marketing Manager, Illumina: Spatial Proteogenomics: NanoString GeoMx Digital Spatial Profiler datasets now available on Illumina BaseSpace Sequence Hub (BSSH).

• Parambir Dulai, MD Associate Professor of Medicine, Northwestern University: Spatial Host-Microbe Interactions in Inflammatory Bowel Disease. Application of GeoMx WTA and CosMx 6K Discovery panel to study IBD and Crohn’s disease.

• Susan Heavey, Ph.D. Lecturer, University College London: Spatial Transcriptomics for Characterization of Advanced Cancer Models. Application of GeoMx WTA and CosMx 1K Human to explore the effects of a panel of targeted therapies in patient derived explants.

• Melissa Davis, Ph.D. Program Lead, Computational Systems Oncology, SAiGENCI: Methods for Multi-scale Analysis of Spatial Transcriptomics Data. Bioinformatics pipeline development for GeoMx DSP and CosMx SMI data analysis.

About NanoString Technologies, Inc.

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics. The CosMx™ Spatial Molecular Imager is a single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, visit www.nanostring.com.

The NanoString logo, NanoString, NanoString Technologies, GeoMx, CosMx, AtoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc., in the United States and/or other countries.

This 2023 Spatial Genomics Summit will include information regarding NanoString’s worldwide products and services, not all of which are available in every country.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230914418572/en/

Doug Farrell Vice President, Investor Relations & Corporate Communications dfarrell@nanostring.com Phone: 206-602-1768

NanoString Technologies (NASDAQ:NSTG)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025

NanoString Technologies (NASDAQ:NSTG)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025